Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
BioXcel Therapeutics, Inc. (BTAI) had Debt to Equity Ratio of -1.15 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$0.64M |
|
$-69.90M |
|
$0.16M |
|
$0.48M |
|
$51.10M |
|
$-50.46M |
|
$-19.44M |
|
$-69.90M |
|
$-69.90M |
|
$-69.90M |
|
$-69.90M |
|
$-69.90M |
|
$-69.90M |
|
$-50.46M |
|
$-50.16M |
|
12.21M |
|
12.21M |
|
$-5.73 |
|
$-5.73 |
|
| Balance Sheet Financials | |
$44.69M |
|
$0.17M |
|
$0.23M |
|
$44.92M |
|
$53.93M |
|
$84.66M |
|
$86.45M |
|
$140.38M |
|
$-95.46M |
|
$-95.46M |
|
$-95.46M |
|
22.33M |
|
| Cash Flow Statement Financials | |
$-57.62M |
|
-- |
|
$56.52M |
|
$29.85M |
|
$28.76M |
|
$-1.10M |
|
$2.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.83 |
|
-- |
|
-- |
|
-7.84 |
|
|
Debt to Equity Ratio |
-1.15 |
74.45% |
|
-7859.97% |
|
-7859.97% |
|
-7813.24% |
|
-10887.38% |
|
-10887.38% |
|
$-57.62M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.23 |
|
2.76 |
|
132.47 |
|
73.22% |
|
73.22% |
|
-155.62% |
|
647.19% |
|
$-4.28 |
|
$-4.72 |
|
$-4.72 |
|